When searching for information regarding Methicillin-Sensitive Staphylococcus Aureus, the specific query "icd 10 code for mssa" is common among medical coders and healthcare professionals. This bacterium is a frequent cause of skin and soft tissue infections, requiring precise classification for accurate billing and epidemiological tracking. The correct code depends heavily on the specific site of infection and the clinical context of the encounter.
Understanding the Clinical Context of MSSA
Methicillin-Sensitive Staphylococcus Aureus refers to strains of the Staphylococcus bacteria that remain susceptible to beta-lactam antibiotics, including methicillin and related drugs like oxacillin. Unlike its resistant counterpart, MRSA, MSSA infections are generally easier to treat, though they can still lead to serious complications if not managed appropriately. The distinction between sensitive and resistant strains is critical for guiding antibiotic therapy and is reflected accurately in the diagnostic coding process.
Primary ICD-10-CM Diagnosis Codes
The core classification for this organism is found within the category of bacterial infections. The primary "icd 10 code for mssa" as a general infectious agent is A49.2, which specifically denotes "Methicillin-sensitive staphylococcus [Staphylococcus aureus] infection." This code is non-billable on its own and requires the use of additional characters to specify the location and manifestation of the illness.
Site-Specific Coding Requirements
To ensure compliance and specificity, coders must transition from the general category to the specific site of infection. For instance, a MSSA infection within the skin and subcutaneous tissue is coded as L03.311 for the left lower extremity or L03.312 for the right lower extremity. When the infection is localized to a cut or laceration, the code L02.911 (Cutaneous abscess, left lower extremity) is often used in conjunction with the organism code to provide a complete picture of the diagnosis.
Encounter Types and Code Modifiers
The context of the medical visit dictates the final code selection. If a patient is admitted to the hospital specifically to receive intravenous antibiotics for a confirmed MSSA infection, the code A49.2 would be sequenced as the primary diagnosis. Conversely, if the patient is being treated for a urinary tract infection and the MSSA is discovered incidentally in a urine culture, the UTI code would take precedence, with A49.2 listed as an additional code to indicate the carrier state or associated condition.
Sequencing and Combination Guidelines
Proper sequencing is essential for accurate medical records. The manifestation or site of the infection is usually listed first, followed by the underlying cause represented by the code for the organism. Coders must utilize the Tabular List of Diseases and Injuries to verify the combination codes available. Using the appropriate 7th character encounter indicator (A, D, or S) is also mandatory to specify whether the encounter is initial, ongoing, or for sequela, completing the specific "icd 10 code for mssa" string for the scenario.
Distinguishing MSSA from MRSA in Billing
It is vital to differentiate between MSSA and MRSA (ICD-10 code A49.22) in the coding process, as this distinction can impact hospital-acquired condition reporting and antimicrobial stewardship programs. While both are staphylococcal infections, the sensitivity profile dictates different treatment pathways. Accurate documentation of the lab results confirming sensitivity ensures that the correct code is applied, preventing claim denials and ensuring appropriate resource allocation within the healthcare facility.
